Refractory post-surgical cystoid macular edema managed following suprachoroidal microcatheterization and delivery of triamcinolone

被引:3
作者
de Smet, Marc D. [1 ,2 ]
Goncerut, Matthieu [1 ]
Asmus, Friedrich [3 ]
Yamamoto, Ron [3 ]
机构
[1] Helvetia Retina Associates, Lausanne, Switzerland
[2] Icahn Sch Med, New York Eye & Ear Infirm Mt Sinai, New York, NY 10029 USA
[3] Oxular Ltd, Oxford, England
关键词
Microcatheterization; CME; Drug visualization; Infrared; Macular edema; OCT; Posterior; Steroid; Suprachoroidal; INTRAVITREAL IMPLANTS; ACETONIDE; INJECTION; SAFETY; UPDATE;
D O I
10.1186/s12886-023-03110-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
BackgroundPost-surgical macular edema (ME) is a common cause of prolonged visual impairment. Here we report on the feasibility and clinical outcomes from the use of a novel suprachoroidal microcatheter to treat post-surgical chronic ME by the posterior suprachoroidal placement of a triamcinolone acetonide (TA) suspension.MethodsTwo patients were catheterized with the Oxulumis suprachoroidal delivery system on two separate occasions starting 5 and 10 mm posterior to the limbus. The catheter only remains in the suprachoroidal space for the time of the drug administration. Visual acuity and spectral domain optical coherence tomography (SD-OCT) changes were followed over several weeks to months to determine the duration of ME resolution.ResultsSuprachoroidal microcatheterization for posterior delivery of triamcinolone was possible in all attempts using the illuminated Oxulumis catheter. No reflux, scleral or choroidal trauma was observed. There was no intraocular pressure rise during the follow-up period. The triamcinolone deposit was visible on infrared imaging and on SD-OCT a choroidal elevation was visible. Both progressively disappeared over time. A rapid resolution of ME associated with improved vision was observed following each injection for 3 to 7 months with a TA dose of 2.4 mg or 4 mg.ConclusionsIn these patients with poorly responsive ME, posterior suprachoroidal TA led to a visible suprachoroidal drug deposit and prolonged visual improvement. The Oxulumis microcatheterization device performed as expected and was not associated with any complications.
引用
收藏
页数:7
相关论文
共 24 条
  • [21] Epidemiology and Course of Disease in Childhood Uveitis
    Smith, Janine A.
    Mackensen, Friederike
    Sen, H. Nida
    Leigh, Julie F.
    Watkins, Angela S.
    Pyatetsky, Dmitry
    Tessler, Howard H.
    Nussenblatt, Robert B.
    Rosenbaum, James T.
    Reed, George F.
    Vitale, Susan
    Smith, Justine R.
    Goldstein, Debra A.
    [J]. OPHTHALMOLOGY, 2009, 116 (08) : 1544 - 1551
  • [22] Comparison of Suprachoroidal Drug Delivery with Subconjunctival and Intravitreal Routes Using Noninvasive Fluorophotometry
    Tyagi, Puneet
    Kadam, Rajendra S.
    Kompella, Uday B.
    [J]. PLOS ONE, 2012, 7 (10):
  • [23] Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis Phase 3 Randomized Trial
    Yeh, Steven
    Khurana, Rahul N.
    Shah, Milan
    Henry, Christopher R.
    Wang, Robert C.
    Kissner, Jennifer M.
    Ciulla, Thomas A.
    Noronha, Glenn
    [J]. OPHTHALMOLOGY, 2020, 127 (07) : 948 - 955
  • [24] SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS A Randomized, Phase 2 Study (DOGWOOD)
    Yeh, Steven
    Kurup, Shree K.
    Wang, Robert C.
    Foster, C. Stephen
    Noronha, Glenn
    Quan Dong Nguyen
    Do, Diana V.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (10): : 1880 - 1888